March 5 (Reuters) - Scinai Immunotherapeutics Ltd 2F5y.F:
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE AGREEMENT
SCINAI IMMUNOTHERAPEUTICS LTD - SALES TO YORKVILLE SUBJECT TO 9.99% BENEFICIAL OWNERSHIP CAP
Further company coverage: [2F5y.F]